This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
activin-a
Activin A
Activin A (INHBA homodimer, chr7p15.2) is a TGF-β superfamily member; ActRIIB/ALK4 → SMAD2/3 suppresses erythropoiesis and promotes PAH vascular remodeling; luspatercept (ActRIIB-Fc) treats MDS/beta-thalassemia; sotatercept reverses PAH (STELLAR trial 2024).
Entry Metadata
| Field | Value |
|---|---|
| ID | activin-a |
| Name | Activin A |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Hoeper MM, Badesch DB, Ghofrani HA, et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023;388(16):1478-1490. · PubMed 36877098
- Fenaux P, Platzbecker U, Mufti GJ, et al. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes. N Engl J Med. 2020;382(2):140-151. · PubMed 31914241